These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 33417605)
21. Uncertainty Modeling of a Modified SEIR Epidemic Model for COVID-19. Wang Y; Wang P; Zhang S; Pan H Biology (Basel); 2022 Aug; 11(8):. PubMed ID: 36009784 [TBL] [Abstract][Full Text] [Related]
22. Impact of self-imposed prevention measures and short-term government-imposed social distancing on mitigating and delaying a COVID-19 epidemic: A modelling study. Teslya A; Pham TM; Godijk NG; Kretzschmar ME; Bootsma MCJ; Rozhnova G PLoS Med; 2020 Jul; 17(7):e1003166. PubMed ID: 32692736 [TBL] [Abstract][Full Text] [Related]
23. SEIR-FMi: A coronavirus disease epidemiological model based on intra-city movement, inter-city movement and medical resource investment. Zhang W; Xie R; Dong X; Li J; Peng P; Dr Santibanez Gonzalez E Comput Biol Med; 2022 Oct; 149():106046. PubMed ID: 36108414 [TBL] [Abstract][Full Text] [Related]
24. Measuring the worldwide spread of COVID-19 using a comprehensive modeling method. Zhou X; Ma X; Gao S; Ma Y; Gao J; Jiang H; Zhu W; Hong N; Long Y; Su L BMC Med Inform Decis Mak; 2023 Sep; 21(Suppl 9):384. PubMed ID: 37715170 [TBL] [Abstract][Full Text] [Related]
25. Transmission Characteristics and Predictive Model for Recent Epidemic Waves of COVID-19 Associated With OMICRON Variant in Major Cities in China. Zheng Y; Wang Y Int J Public Health; 2022; 67():1605177. PubMed ID: 36405530 [No Abstract] [Full Text] [Related]
26. Effect of different resumption strategies to flatten the potential COVID-19 outbreaks amid society reopens: a modeling study in China. Ge Y; Zhang WB; Wang J; Liu M; Ren Z; Zhang X; Zhou C; Tian Z BMC Public Health; 2021 Mar; 21(1):604. PubMed ID: 33781224 [TBL] [Abstract][Full Text] [Related]
27. Impact of Systematic Factors on the Outbreak Outcomes of the Novel COVID-19 Disease in China: Factor Analysis Study. Cao Z; Tang F; Chen C; Zhang C; Guo Y; Lin R; Huang Z; Teng Y; Xie T; Xu Y; Song Y; Wu F; Dong P; Luo G; Jiang Y; Zou H; Chen YQ; Sun L; Shu Y; Du X J Med Internet Res; 2020 Nov; 22(11):e23853. PubMed ID: 33098287 [TBL] [Abstract][Full Text] [Related]
28. [Epidemic trend of COVID-19 in Chinese mainland]. Zhu ZB; Zhong CK; Zhang KX; Dong C; Peng H; Xu T; Wang AL; Guo ZR; Zhang YH Zhonghua Yu Fang Yi Xue Za Zhi; 2020 Jun; 54(6):620-624. PubMed ID: 32125133 [No Abstract] [Full Text] [Related]
29. Forecasting the long-term trend of COVID-19 epidemic using a dynamic model. Sun J; Chen X; Zhang Z; Lai S; Zhao B; Liu H; Wang S; Huan W; Zhao R; Ng MTA; Zheng Y Sci Rep; 2020 Dec; 10(1):21122. PubMed ID: 33273592 [TBL] [Abstract][Full Text] [Related]
30. Early warning and predicting of COVID-19 using zero-inflated negative binomial regression model and negative binomial regression model. Zhou W; Huang D; Liang Q; Huang T; Wang X; Pei H; Chen S; Liu L; Wei Y; Qin L; Xie Y BMC Infect Dis; 2024 Sep; 24(1):1006. PubMed ID: 39300391 [TBL] [Abstract][Full Text] [Related]
31. The effect of control measures on COVID-19 transmission in Italy: Comparison with Guangdong province in China. Liu PY; He S; Rong LB; Tang SY Infect Dis Poverty; 2020 Sep; 9(1):130. PubMed ID: 32938502 [TBL] [Abstract][Full Text] [Related]
32. Modelling the evolution trajectory of COVID-19 in Wuhan, China: experience and suggestions. Liu M; Ning J; Du Y; Cao J; Zhang D; Wang J; Chen M Public Health; 2020 Jun; 183():76-80. PubMed ID: 32442842 [TBL] [Abstract][Full Text] [Related]
33. China's Fight Against COVID-19: What We Have Done and What We Should Do Next? Cheng S; Zhao Y; Kaminga AC; Zhang X; Xu H Front Public Health; 2022; 10():548056. PubMed ID: 35844877 [TBL] [Abstract][Full Text] [Related]
34. The impact of awareness diffusion on the spread of COVID-19 based on a two-layer SEIR/V-UA epidemic model. Zhao X; Zhou Q; Wang A; Zhu F; Meng Z; Zuo C J Med Virol; 2021 Jul; 93(7):4342-4350. PubMed ID: 33738825 [TBL] [Abstract][Full Text] [Related]
35. Feasibility study of mitigation and suppression strategies for controlling COVID-19 outbreaks in London and Wuhan. Yang P; Qi J; Zhang S; Wang X; Bi G; Yang Y; Sheng B; Yang G PLoS One; 2020; 15(8):e0236857. PubMed ID: 32760081 [TBL] [Abstract][Full Text] [Related]
36. Model-Based Evaluation of Transmissibility and Intervention Measures for a COVID-19 Outbreak in Xiamen City, China. Liu W; Guo Z; Abudunaibi B; Ouyang X; Wang D; Yang T; Deng B; Huang J; Zhao B; Su Y; Su C; Chen T Front Public Health; 2022; 10():887146. PubMed ID: 35910883 [TBL] [Abstract][Full Text] [Related]
37. Population migration, spread of COVID-19, and epidemic prevention and control: empirical evidence from China. Hu Z; Wu Y; Su M; Xie L; Zhang A; Lin X; Nie Y BMC Public Health; 2021 Mar; 21(1):529. PubMed ID: 33731053 [TBL] [Abstract][Full Text] [Related]
38. A new SEAIRD pandemic prediction model with clinical and epidemiological data analysis on COVID-19 outbreak. Liu XX; Fong SJ; Dey N; Crespo RG; Herrera-Viedma E Appl Intell (Dordr); 2021; 51(7):4162-4198. PubMed ID: 34764574 [TBL] [Abstract][Full Text] [Related]
39. Transmission patterns of COVID-19 in the mainland of China and the efficacy of different control strategies: a data- and model-driven study. Zu J; Li ML; Li ZF; Shen MW; Xiao YN; Ji FP Infect Dis Poverty; 2020 Jul; 9(1):83. PubMed ID: 32631426 [TBL] [Abstract][Full Text] [Related]
40. Spatio-temporal distribution characteristics and influencing factors of COVID-19 in China. Chen Y; Li Q; Karimian H; Chen X; Li X Sci Rep; 2021 Feb; 11(1):3717. PubMed ID: 33580113 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]